In vitro and computational evaluation of the erectogenic and anti-diabetic potential of ethanol extract of Hymenodictyon pachyantha stem bark

体外和计算机评价 Hymenodictyon pachyantha 茎皮乙醇提取物的促勃起和抗糖尿病潜力

阅读:1

Abstract

Medicinal plants and their phytochemicals are gaining attention in managing erectile dysfunction (ED) and diabetes. This study investigated the erectogenic and antidiabetic potentials of ethanol extract of Hymenodictyon pachyantha K.Krause (EHP), using in vitro and in silico approaches. The erectogenic potential of EHP was evaluated via inhibition of phosphodiesterase-5 (PDE-5), arginase, and acetylcholinesterase (AchE) activities, whereas the antidiabetic property was determined via inhibition of α-amylase and α-glucosidase activities. Our data revealed that EHP inhibited PDE-5 (IC(50) = 0.58 mg/ml), arginase (IC(50) = 0.57 mg/ml), and AchE (IC(50) = 0.48 mg/ml), comparable with the reference drug, sildenafil (IC(50) = 0.55 mg/ml). The results also showed that EHP inhibited α-amylase (IC50 = 0.81 mg/ml) and α-glucosidase (IC(50) = 0.23 mg/ml) compared with the reference drug acarbose, which showed IC50 = 0.66 mg/ml and 0.25 mg/ml, respectively. The presence of rutin, naringin, spartein, epicatechin, catechin, and resveratrol, among others, was determined in EHP using gas chromatography and was subjected to computational studies, including molecular docking to predict enzyme interactions, and ADMET analysis to determine their drug-like properties. Rutin and naringin had the highest binding affinity against PDE-5, arginase, and AchE. Sapogenin and rutin demonstrated the highest binding affinity to the active site of α-amylase and α-glucosidase, respectively, compared to the reference antidiabetic compound, acarbose. Overall, our findings showed that EHP inhibited PDE-5, arginase, AchE, α-amylase, and α-glucosidase, with phytochemicals particularly rutin, naringin, catechin, and sapogenin showing the strongest docking affinities and favorable ADMET properties, indicating that EHP contains compounds with erectogenic and antidiabetic potentials; however, further research is required to confirm the safety and efficacy of EHP's phytocompounds using in vivo experiments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40203-025-00510-6.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。